{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T09:44:57Z","timestamp":1776851097252,"version":"3.51.2"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>OBJECTIVES:<\/jats:title>\n            <jats:p>To test the hypothesis that relatively lower clot strength on thromboelastography maximum amplitude (MA) is associated with development of venous thromboembolism (VTE) in critically ill patients with COVID-19.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DESIGN:<\/jats:title>\n            <jats:p>Prospective, observational cohort study.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>SETTING:<\/jats:title>\n            <jats:p>Tertiary care, academic medical center in Nashville, TN.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>PATIENTS:<\/jats:title>\n            <jats:p>Patients with acute respiratory failure from COVID-19 pneumonia admitted to the adult medical ICU without known VTE at enrollment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>INTERVENTIONS:<\/jats:title>\n            <jats:p>None.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MEASUREMENTS AND MAIN RESULTS:<\/jats:title>\n            <jats:p>Ninety-eight consecutive critically ill adults with laboratory-confirmed COVID-19 were enrolled. Thromboelastography parameters and conventional coagulation parameters were measured on days 0 (within 48\u2009hr of ICU admission), 3, 5, and 7 after enrollment. The primary outcome was diagnosis of VTE with confirmed deep venous thrombosis and\/or pulmonary embolism by clinical imaging or autopsy. Twenty-six patients developed a VTE. Multivariable regression controlling for antiplatelet exposure and anticoagulation dose with death as a competing risk found that lower MA was associated with increased risk of VTE. Each 1\u2009mm increase in enrollment and peak MA was associated with an 8% and 14% decrease in the risk of VTE, respectively (enrollment MA: subdistribution hazard ratio [SHR], 0.92; 95% CI, 0.87\u20130.97; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.003 and peak MA: SHR, 0.86; 95% CI, 0.81\u20130.91; <jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.001). Lower enrollment platelet counts and fibrinogen levels were also associated with increased risk of VTE (<jats:italic toggle=\"yes\">p<\/jats:italic> = 0.002 and <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.01, respectively). Platelet count and fibrinogen level were positively associated with MA (multivariable model: adjusted <jats:italic toggle=\"yes\">R<\/jats:italic>\n                                 <jats:sup>2<\/jats:sup> = 0.51; <jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.001).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>When controlling for the competing risk of death, lower enrollment and peak MA were associated with increased risk of VTE. Lower platelet counts and fibrinogen levels at enrollment were associated with increased risk of VTE. The association of diminished MA, platelet counts, and fibrinogen with VTE may suggest a relative consumptive coagulopathy in critically ill patients with COVID-19.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cce.0000000000000618","type":"journal-article","created":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T19:03:14Z","timestamp":1642791794000},"page":"e0618","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Serial Thromboelastography and the Development of Venous Thromboembolism in Critically Ill Patients With COVID-19"],"prefix":"10.1097","volume":"4","author":[{"given":"Tanya K.","family":"Marvi","sequence":"first","affiliation":[{"name":"Department of Medicine, Vanderbilt University Medical Center, Nashville, TN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William B.","family":"Stubblefield","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, TN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin F.","family":"Tillman","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark W.","family":"Tenforde","sequence":"additional","affiliation":[{"name":"COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manish M.","family":"Patel","sequence":"additional","affiliation":[{"name":"COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher J.","family":"Lindsell","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wesley H.","family":"Self","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, TN."},{"name":"Vanderbilt Institute for Clinical and Translational Research (VICTR), Vanderbilt University Medical Center, Nashville, TN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos G.","family":"Grijalva","sequence":"additional","affiliation":[{"name":"Department of Health Policy, Vanderbilt University Medical Center, Nashville, TN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd W.","family":"Rice","sequence":"additional","affiliation":[{"name":"Vanderbilt Institute for Clinical and Translational Research (VICTR), Vanderbilt University Medical Center, Nashville, TN."},{"name":"Division of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the Influenza and Other Viruses in the Acutely Ill (IVY) Network","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,1,18]]},"reference":[{"key":"R1-20250211","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1097\/CCM.0000000000004471","article-title":"Thromboelastography profiles of critically ill patients with coronavirus disease 2019.","volume":"48","author":"Yuriditsky","year":"2020","journal-title":"Crit Care Med"},{"key":"R2-20250211","doi-asserted-by":"crossref","first-page":"e783","DOI":"10.1097\/CCM.0000000000004466","article-title":"Routine venous thromboembolism prophylaxis may be inadequate in the hypercoagulable state of severe coronavirus disease 2019.","volume":"48","author":"Maatman","year":"2020","journal-title":"Crit Care Med"},{"key":"R3-20250211","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1001\/jama.2020.13372","article-title":"Thrombosis in hospitalized patients with COVID-19 in a New York City Health System.","volume":"324","author":"Bilaloglu","year":"2020","journal-title":"JAMA"},{"key":"R4-20250211","doi-asserted-by":"crossref","first-page":"e0354","DOI":"10.1097\/CCE.0000000000000354","article-title":"Thromboelastography parameters and platelet count on admission to the ICU and the development of venous thromboembolism in patients with coronavirus disease 2019.","volume":"3","author":"Marvi","year":"2021","journal-title":"Crit Care Explor"},{"key":"R5-20250211","doi-asserted-by":"crossref","first-page":"e2011192","DOI":"10.1001\/jamanetworkopen.2020.11192","article-title":"Thromboelastographic results and hypercoagulability syndrome in patients with coronavirus disease 2019 who are critically ill.","volume":"3","author":"Mortus","year":"2020","journal-title":"JAMA Netw Open"},{"key":"R6-20250211","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s11239-020-02130-7","article-title":"Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia.","volume":"50","author":"Pavoni","year":"2020","journal-title":"J Thromb Thrombolysis"},{"key":"R7-20250211","doi-asserted-by":"crossref","first-page":"e1159","DOI":"10.1097\/CCM.0000000000004545","article-title":"In response to \u201ccoagulopathy of coronavirus disease 2019.\u201d","volume":"48","author":"Ng","year":"2020","journal-title":"Crit Care Med"},{"key":"R8-20250211","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jamcollsurg.2020.05.007","article-title":"Fibrinolysis shutdown correlation with thromboembolic events in severe COVID-19 infection.","volume":"231","author":"Wright","year":"2020","journal-title":"J Am Coll Surg"},{"key":"R9-20250211","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1111\/jth.14850","article-title":"Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis.","volume":"18","author":"Panigada","year":"2020","journal-title":"J Thromb Haemost"},{"key":"R10-20250211","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3390\/diagnostics11020172","article-title":"The role of TEG analysis in patients with COVID-19-associated coagulopathy: A systematic review.","volume":"11","author":"Hartmann","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"R11-20250211","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s11239-020-02300-7","article-title":"Thromboelastography findings in critically ill COVID-19 patients.","volume":"51","author":"Salem","year":"2021","journal-title":"J Thromb Thrombolysis"},{"key":"R12-20250211","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s13054-020-03077-0","article-title":"The unique characteristics of COVID-19 coagulopathy.","volume":"24","author":"Iba","year":"2020","journal-title":"Crit Care"},{"key":"R13-20250211","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.","volume":"18","author":"Tang","year":"2020","journal-title":"J Thromb Haemost"},{"key":"R14-20250211","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12185-020-03029-y","article-title":"COVID-19-associated coagulopathy and disseminated intravascular coagulation.","volume":"113","author":"Asakura","year":"2021","journal-title":"Int J Hematol"},{"key":"R15-20250211","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1055\/s-0037-1616068","article-title":"Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation.","volume":"86","author":"Taylor","year":"2001","journal-title":"Thromb Haemost"},{"key":"R16-20250211","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1538-7836.2007.02313.x","article-title":"The scoring system of the Scientific and Standardisation Committee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Haemostasis: A 5-year overview.","volume":"5","author":"Toh","year":"2007","journal-title":"J Thromb Haemost"},{"key":"R17-20250211","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/jth.15138","article-title":"Development and implementation of common data elements for venous thromboembolism research: On behalf of SSC Subcommittee on official Communication from the SSC of the ISTH.","volume":"19","author":"Le Gal","year":"2021","journal-title":"J Thromb Haemost"},{"key":"R18-20250211","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients.","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"key":"R19-20250211","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: Building an international community of software platform partners.","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"R20-20250211","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research Electronic Data Capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support.","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"R21-20250211","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk.","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Statist Assoc"},{"key":"R22-20250211","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa2103417","article-title":"Therapeutic anticoagulation with heparin in critically ill patients with Covid-19.","volume":"385","author":"Goligher","year":"2021","journal-title":"N Engl J Med"},{"key":"R23-20250211","doi-asserted-by":"crossref","first-page":"5568982","DOI":"10.1155\/2021\/5568982","article-title":"A case series of thromboelastography-guided anticoagulation in COVID-19 patients with inherited and acquired hypercoagulable states.","volume":"2021","author":"Thomas","year":"2021","journal-title":"Case Rep Med"},{"key":"R24-20250211","article-title":"The value of thromboelastography (TEG) in COVID-19 critical illness as illustrated by a case series.","author":"Wang","year":"2021","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R25-20250211","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.3390\/jcm10143097","article-title":"Preventing thrombohemorrhagic complications of heparinized COVID-19 patients using adjunctive thromboelastography: A retrospective study.","volume":"10","author":"Bunch","year":"2021","journal-title":"J Clin Med"},{"key":"R26-20250211","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/MBC.0000000000001069","article-title":"Thrombogenicity markers for early diagnosis and prognosis in COVID-19: A change from the current paradigm?","volume":"32","author":"Gurbel","year":"2021","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R27-20250211","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1177\/0885066621997039","article-title":"Association of D-dimer and fibrinogen with hypercoagulability in COVID-19 requiring extracorporeal membrane oxygenation.","volume":"36","author":"Chandel","year":"2021","journal-title":"J Intensive Care Med"},{"key":"R28-20250211","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/TA.0b013e3182826d7e","article-title":"Platelets are dominant contributors to hypercoagulability after injury.","volume":"74","author":"Harr","year":"2013","journal-title":"J Trauma Acute Care Surg"},{"key":"R29-20250211","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.surg.2009.06.054","article-title":"Rapid thrombelastography (r-TEG) identifies hypercoagulability and predicts thromboembolic events in surgical patients.","volume":"146","author":"Kashuk","year":"2009","journal-title":"Surgery"},{"key":"R30-20250211","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1055\/a-1477-3829","article-title":"Platelet count rose while D-dimer levels dropped as deaths and thrombosis declined, an observational study on anticoagulation shift in COVID-19.","volume":"121","author":"Sj\u00f6str\u00f6m","year":"2021","journal-title":"Thromb Haemost"},{"key":"R31-20250211","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s11239-020-02134-3","article-title":"COVID-19 update: Covid-19-associated coagulopathy.","volume":"50","author":"Becker","year":"2020","journal-title":"J Thromb Thrombolysis"},{"key":"R32-20250211","doi-asserted-by":"crossref","first-page":"E191","DOI":"10.3390\/jcm10020191","article-title":"Proposal of the definition for COVID-19-associated coagulopathy.","volume":"10","author":"Iba","year":"2021","journal-title":"J Clin Med"},{"key":"R33-20250211","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1182\/blood-2017-10-804096","article-title":"How I treat disseminated intravascular coagulation.","volume":"131","author":"Levi","year":"2018","journal-title":"Blood"},{"key":"R34-20250211","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1161\/CIRCULATIONAHA.120.048488","article-title":"Immunothrombotic dysregulation in COVID-19 pneumonia is associated with respiratory failure and coagulopathy.","volume":"142","author":"Nicolai","year":"2020","journal-title":"Circulation"}],"container-title":["Critical Care Explorations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000000618","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T19:00:58Z","timestamp":1739300458000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000000618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/cce.0000000000000618","relation":{},"ISSN":["2639-8028"],"issn-type":[{"value":"2639-8028","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]}}}